| Filed On | Filing |
|---|---|
| 02 Oct 2026 |
Form 4: Raben David, Chief Medical Officer
Granted 575,000 Stock Option (Right to Buy) |
| 02 Oct 2026 |
Form 3: Raben David, Chief Medical Officer
No securities owned |
| 14 Aug 2026 | SCHEDULE 13G |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 11 Aug 2026 | 10-Q |
| 11 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 13 Jul 2026 |
Form 3: Iannone Robert, Director
No securities owned |
| 13 Jul 2026 |
Form 4: Iannone Robert, Director
Granted 60,000 Stock Option (Right to Buy) |
| 13 Jul 2026 |
Form 3: Borellini Flavia, Director
No securities owned |
| 13 Jul 2026 |
Form 4: Borellini Flavia, Director
Granted 60,000 Stock Option (Right to Buy) |
| 13 Jul 2026 | 8-K: Departure/Election of Directors or Officers; Compensation |
| 12 Jun 2026 |
Form 4: Crowell Gayle A, Director
Granted 70,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Mccourt Thomas A, Director
Granted 70,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Krognes Steve E., Director
Granted 70,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Curnutte John T, Director
Granted 70,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Huh Hoyoung, Director
Granted 70,000 Stock Option (Right to Buy) |
| 12 Jun 2026 |
Form 4: Cline Darren S, Director
Granted 70,000 Stock Option (Right to Buy) |
| 11 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 11 May 2026 | 10-Q |
| 11 May 2026 | 8-K: Results of Operations and Financial Condition |
Loading...
